IDEX Corporation (IEX)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 596,100 617,500 587,100 586,700 586,900 575,700 512,700 476,700 449,400 431,668 419,816 388,480 377,778 373,560 374,906 417,251 425,521 426,808 427,966 421,883
Total stockholders’ equity US$ in thousands 3,541,400 3,387,100 3,278,700 3,229,200 3,039,300 2,802,800 2,788,200 2,899,000 2,803,100 2,726,240 2,672,800 2,609,930 2,540,200 2,396,530 2,261,040 2,229,790 2,263,230 2,163,050 2,112,040 2,055,230
ROE 16.83% 18.23% 17.91% 18.17% 19.31% 20.54% 18.39% 16.44% 16.03% 15.83% 15.71% 14.88% 14.87% 15.59% 16.58% 18.71% 18.80% 19.73% 20.26% 20.53%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $596,100K ÷ $3,541,400K
= 16.83%

Idex Corporation's return on equity (ROE) has exhibited some fluctuations over the past eight quarters, ranging from a high of 20.54% in Q3 2022 to a low of 16.44% in Q1 2022. Generally, the ROE has been above 16%, indicating that the company has been generating a sufficient return for its shareholders during this period.

The downward trend in ROE from Q3 2022 to Q1 2022 may suggest that the company faced challenges in maintaining profitability or efficiently utilizing its equity investments. However, the subsequent increase in ROE from Q1 2022 to Q3 2022 indicates a potential improvement in the company's financial performance.

Idex Corporation's ability to consistently achieve ROE above 16% reflects a satisfactory level of profitability relative to its equity base. Investors and stakeholders may find the overall trend in ROE to be positive, although closer analysis of the underlying factors driving these fluctuations would be necessary to fully assess the company's financial health and performance.


Peer comparison

Dec 31, 2023